Article

Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?

2021-07-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>There are 3 prognostic stratification tools used in clinics for endometrial cancer: ESMO-ESGO-ESTRO 2016, ProMisE, and ESGO-ESTRO-ESP 2020. However, these methods are not sufficiently accurate to address the prognosis and adjuvant therapy. Some other previously explored biomarkers have also shown prognostic relevance. The aim of this study was to investigate wheth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3253112b-3af6-5636-8c05-572efc5181c2
DOI: 10.21203/rs.3.rs-682631/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?DOI 10.21203/rs.3.rs-682631/v1Read

[The influence of molecular classification in the selection of postoperative adjuvant therapy in endometrial carcinoma].Semantic proximity Read

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables.Semantic proximity Read

Molecular classification-driven stage migration and prognostic risk stratification in endometrial cancers: FIGO 2023 vs FIGO 2009.Semantic proximity Read

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read

Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.Semantic proximity Read

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer.Semantic proximity Read

FIGO 2023 staging system with/without molecular classification vs. FIGO 2009 in 172 endometrial cancer patients.Semantic proximity Read

Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis.Semantic proximity Read

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancerSemantic proximity Read

Molecular classification improves preoperative risk assessment of endometrial cancer.Semantic proximity Read

Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer.Semantic proximity Read